Gland Pharma Ltd
| Particulars | Mar 2026 | Dec 2025 | Sep 2025 |
|---|---|---|---|
| Revenue | 1,367.95 | 1,237.72 | 1,156.74 |
| Operating Expense | 753.88 | 780.23 | 699.27 |
| Net Profit | 420.45 | 307.85 | 302 |
| Net Profit Margin | 30.74% | 24.87% | 26.11% |
| Earning Per Share | 25.52 | 18.68 | 18.33 |
| EBIDTA | 612.94 | 463.09 | 456.71 |
| Effective Tax Rate | 23.32% | 24.09% | 23.15% |
Particulars
Mar 2026
Revenue1,367.95
Operating Expense753.88
Net Profit420.45
Net Profit Margin30.74
Earning Per Share25.52
EBIDTA612.94
Effective Tax Rate23.32
